Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer. Kim HG, Kang SY, Kim KM, Kim JY, et al. Anticancer Res 2025;45:2575-2586.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim HG, Kang SY, Kim KM, Kim JY, et al. Combined Biomarkers for Prediction of Immune Checkpoint Inhibitor Response in Patients With Triple-negative Breast Cancer. Anticancer Res 2025;45:2575-2586.
PMID: 40425338